Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Erukainure_2021_Endocr.Metab.Immune.Disord.Drug.Targets_21_688

Reference

Title: Cola Nitida (Kola Nuts) Attenuates Hepatic Injury in Type 2 Diabetes by Improving Antioxidant and Cholinergic Dysfunctions and Dysregulated Lipid Metabolism
Erukainure OL, Sanni O, Salau VF, Koorbanally NA, Islam MS
Ref: Endocr Metab Immune Disord Drug Targets, 21:688, 2021 : PubMed

        



Related information



Citations formats

Erukainure OL, Sanni O, Salau VF, Koorbanally NA, Islam MS (2021)
Cola Nitida (Kola Nuts) Attenuates Hepatic Injury in Type 2 Diabetes by Improving Antioxidant and Cholinergic Dysfunctions and Dysregulated Lipid Metabolism
Endocr Metab Immune Disord Drug Targets 21: 688-699

Erukainure OL, Sanni O, Salau VF, Koorbanally NA, Islam MS (2021)
Endocr Metab Immune Disord Drug Targets 21: 688-699



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer